InstitutePeopleOliver Plettenburg
List of publications

List of Publications Prof. Dr. Oliver Plettenburg


Showing entries 1 - 10 out of 32
1 2 3 4 Last

2022


Napolitano, V., Dabrowska, A., Schorpp, K., Mourão, A., Barreto-Duran, E., Benedyk, M., Botwina, P., Brandner, S., Bostock, M., Chykunova, Y., Czarna, A., Dubin, G., Fröhlich, T., Hölscher, M., Jedrysik, M., Matsuda, A., Owczarek, K., Pachota, M., Plettenburg, O., ... Pyrc, K. (2022). Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses. Cell Chemical Biology, 29(5), 774-784. doi.org/10.1016/j.chembiol.2021.11.006

Yin, H., Karayel, O., Chao, Y. Y., Seeholzer, T., Hamp, I., Plettenburg, O., Gehring, T., Zielinski, C., Mann, M., & Krappmann, D. (2022). A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells. Cellular and Molecular Life Sciences, 79(2), [112]. doi.org/10.1007/s00018-022-04154-z


2021


Gerckens, M., Schorpp, K., Pelizza, F., Wögrath, M., Reichau, K., Ma, H., Dworsky, A. M., Sengupta, A., Stoleriu, M. G., Heinzelmann, K., Merl-Pham, J., Irmler, M., Alsafadi, H. N., Trenkenschuh, E., Sarnova, L., Jirouskova, M., Frieß, W., Hauck, S. M., Beckers, J., ... Burgstaller, G. (2021). Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics. Science advances, 7(52), [eabb3673]. doi.org/10.1126/sciadv.abb3673

O'Neill, T. J., Seeholzer, T., Gewies, A., Gehring, T., Giesert, F., Hamp, I., Graß, C., Schmidt, H., Kriegsmann, K., Tofaute, M. J., Demski, K., Poth, T., Rosenbaum, M., Schnalzger, T., Ruland, J., Göttlicher, M., Kriegsmann, M., Naumann, R., Heissmeyer, V., ... Krappmann, D. (2021). TRAF6 prevents fatal inflammation by homeostatic suppression of MALT1 protease. Science Immunology, 6(65), [eabh2095]. doi.org/10.1126/sciimmunol.abh2095

Fino, R., Lenhart, D., Kalel, V. C., Softley, C. A., Napolitano, V., Byrne, R., Schliebs, W., Dawidowski, M., Erdmann, R., Sattler, M., Schneider, G., Plettenburg, O., & Popowicz, G. M. (2021). Computer-Aided Design and Synthesis of a New Class of PEX14 Inhibitors: Substituted 2,3,4,5-Tetrahydrobenzo[F][1,4]oxazepines as Potential New Trypanocidal Agents. Journal of Chemical Information and Modeling, 61(10), 5256-5268. doi.org/10.1021/acs.jcim.1c00472

Rai, A., Klare, J. P., Reinke, P. Y. A., Englmaier, F., Fohrer, J., Fedorov, R., Taft, M. H., Chizhov, I., Curth, U., Plettenburg, O., & Manstein, D. J. (2021). Structural and biochemical characterization of a dye-decolorizing peroxidase from dictyostelium discoideum. International Journal of Molecular Sciences, 22(12), [6265]. doi.org/10.3390/ijms22126265

Hofmeister, A., Jahn-Hofmann, K., Brunner, B., Helms, M. W., Metz-Weidmann, C., Krack, A., Kurz, M., Li, Z., Weitzenberg, M. M., Pflimlin, E., Plettenburg, O., & Scheidler, S. (2021). Syntheses of Morpholine-Based Nucleotide Analogs for Hepatic siRNA Targeting and Stabilization. Journal of medicinal chemistry, 64(10), 6838-6855. doi.org/10.1021/acs.jmedchem.1c00144

Liu, N., O'Connor, P., Gujrati, V., Gorpas, D., Glasl, S., Blutke, A., Walch, A., Kleigrewe, K., Sattler, M., Plettenburg, O., & Ntziachristos, V. (2021). Facile Synthesis of a Croconaine-Based Nanoformulation for Optoacoustic Imaging and Photothermal Therapy. Advanced healthcare materials, 10(9), [2002115]. doi.org/10.1002/adhm.202002115

Eriksson, O., Velikyan, I., Haack, T., Bossart, M., Evers, A., Lorenz, K., Laitinen, I., Larsen, P. J., Plettenburg, O., Johansson, L., Pierrou, S., & Wagner, M. (2021). Drug Occupancy Assessment at the Glucose-Dependent Insulinotropic Polypeptide Receptor by Positron Emission Tomography. DIABETES, 70(4), 842-853. doi.org/10.2337/db20-1096

Hartleben, G., Schorpp, K., Kwon, Y., Betz, B., Tsokanos, F. F., Dantes, Z., Schäfer, A., Rothenaigner, I., Monroy Kuhn, J. M., Morigny, P., Mehr, L., Lin, S., Seitz, S., Tokarz, J., Artati, A., Adamsky, J., Plettenburg, O., Lutter, D., Irmler, M., ... Berriel Diaz, M. (2021). Combination therapies induce cancer cell death through the integrated stress response and disturbed pyrimidine metabolism. EMBO molecular medicine, 13(4), [e12461]. doi.org/10.15252/emmm.202012461


Showing entries 1 - 10 out of 32
1 2 3 4 Last